These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21375345)

  • 1. Homogeneous immunosubtraction integrated with sample preparation enabled by a microfluidic format.
    Apori AA; Herr AE
    Anal Chem; 2011 Apr; 83(7):2691-8. PubMed ID: 21375345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chip-based immunoassays.
    Apori AA; Herr AE
    Methods Mol Biol; 2013; 919():233-48. PubMed ID: 22976105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
    Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
    Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidic validation of diagnostic protein markers for spontaneous cerebrospinal fluid rhinorrhea.
    Apori AA; Brozynski MN; El-Sayed IH; Herr AE
    J Proteome Res; 2013 Mar; 12(3):1254-65. PubMed ID: 23343621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrostatic protein immobilization using charged polyacrylamide gels and cationic detergent microfluidic Western blotting.
    Kim D; Karns K; Tia SQ; He M; Herr AE
    Anal Chem; 2012 Mar; 84(5):2533-40. PubMed ID: 22304398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury.
    Kay AD; Petzold A; Kerr M; Keir G; Thompson EJ; Nicoll JA
    J Neurotrauma; 2003 Mar; 20(3):243-50. PubMed ID: 12820678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.
    Coulthart MB; Jansen GH; Olsen E; Godal DL; Connolly T; Choi BC; Wang Z; Cashman NR
    BMC Neurol; 2011 Oct; 11():133. PubMed ID: 22032272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B.
    Bellander BM; Olafsson IH; Ghatan PH; Bro Skejo HP; Hansson LO; Wanecek M; Svensson MA
    Acta Neurochir (Wien); 2011 Jan; 153(1):90-100. PubMed ID: 20686797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100B protein in clinical diagnostics: assay specificity.
    Heizmann CW
    Clin Chem; 2004 Jan; 50(1):249-51. PubMed ID: 14709667
    [No Abstract]   [Full Text] [Related]  

  • 10. Microfluidic barcode assay for antibody-based confirmatory diagnostics.
    Araz MK; Apori AA; Salisbury CM; Herr AE
    Lab Chip; 2013 Oct; 13(19):3910-20. PubMed ID: 23925585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CSF biomarkers and secondary insults following severe traumatic brain injury.
    Stein DM; Kufera JA; Lindell A; Murdock KR; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
    Neurocrit Care; 2011 Apr; 14(2):200-7. PubMed ID: 21210304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.
    Hayakata T; Shiozaki T; Tasaki O; Ikegawa H; Inoue Y; Toshiyuki F; Hosotubo H; Kieko F; Yamashita T; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2004 Aug; 22(2):102-7. PubMed ID: 15257081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases.
    Ondruschka B; Pohlers D; Sommer G; Schober K; Teupser D; Franke H; Dressler J
    J Neurotrauma; 2013 Nov; 30(22):1862-71. PubMed ID: 23796187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of specific antibodies using immunosubtraction and capillary electrophoresis instrumentation.
    Paquette DM; Banks PR
    Electrophoresis; 2001 Aug; 22(12):2391-7. PubMed ID: 11519941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-microchannel, multistep assay reports protein size and immunoaffinity.
    Chen X; Kapil MA; Hughes AJ; Herr AE
    Anal Chem; 2011 Sep; 83(17):6573-9. PubMed ID: 21834519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
    Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B
    J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury.
    Kleindienst A; Meissner S; Eyupoglu IY; Parsch H; Schmidt C; Buchfelder M
    Acta Neurochir Suppl; 2010; 106():247-50. PubMed ID: 19812958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid.
    Ramström M; Zuberovic A; Grönwall C; Hanrieder J; Bergquist J; Hober S
    Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):159-66. PubMed ID: 18412540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoinductive effect of cerebrospinal fluid from brain-injured patients.
    Gautschi OP; Toffoli AM; Joesbury KA; Skirving AP; Filgueira L; Zellweger R
    J Neurotrauma; 2007 Jan; 24(1):154-62. PubMed ID: 17263679
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.